US Stock MarketDetailed Quotes

CDT Conduit Pharmaceuticals

Watchlist
  • 0.5605
  • +0.0040+0.72%
Trading Apr 24 12:11 ET
5.76MMarket Cap-0.03P/E (TTM)

About Conduit Pharmaceuticals Company

Conduit Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of clinical assets to address the unmet medical needs of patients, through exclusive relationships in the areas of autoimmune disease and idiopathic male infertility. The company is headquartered in Naples, FL.

Company Profile

SymbolCDT
Company NameConduit Pharmaceuticals
Listing DateMar 28, 2022
CEODr. Andrew James Regan
MarketNASDAQ
Employees6
Fiscal Year Ends12-31
Address4581 Tamiami Trail North,Suite 200
CityNaples
ProvinceFlorida
CountryUnited States of America
Zip Code34103
Phone1-646-491-9132

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Andrew James Regan
  • Director and Chief Executive Officer
  • 842.08K
  • James Bligh
  • Director, Principal Accounting Officer and Interim Chief Financial Officer
  • 692.94K
  • Dr. Freda C. Lewis-Hall,M.D.
  • Chairman of the Board
  • 101.50K
  • Chele Chiavacci Farley
  • Independent Director
  • 181.85K
  • Simon Fry
  • Independent Director
  • 21.00K

Market Insights

Discussing

Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks Show More

Discussing

FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Unlock Now
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

Unlock Now

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.